These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10647762)

  • 61. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.
    Harrison L; McGinnis J; Crowther M; Ginsberg J; Hirsh J
    Arch Intern Med; 1998 Oct; 158(18):2001-3. PubMed ID: 9778199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Nov; 157(20):2317-21. PubMed ID: 9361572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin.
    Goldhaber SZ; Morrison RB; Diran LL; Creager MA; Lee TH
    Arch Intern Med; 1998 Nov; 158(21):2325-8. PubMed ID: 9827783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
    Hull RD; Pineo GF; Brant RF; Mah AF; Burke N; Dear R; Wong T; Cook R; Solymoss S; Poon MC; Raskob G;
    Am J Med; 2006 Dec; 119(12):1062-72. PubMed ID: 17145251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
    Levine M; Gent M; Hirsh J; Leclerc J; Anderson D; Weitz J; Ginsberg J; Turpie AG; Demers C; Kovacs M
    N Engl J Med; 1996 Mar; 334(11):677-81. PubMed ID: 8594425
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during haemodialysis.
    Hoy SM; Scott LJ; Plosker GL
    Drugs; 2010 Jul; 70(10):1319-47. PubMed ID: 20568836
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
    Théry C; Simonneau G; Meyer G; Hélénon O; Bridey F; Armagnac C; d'Azemar P; Coquart JP
    Circulation; 1992 Apr; 85(4):1380-9. PubMed ID: 1313340
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
    Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
    Charbonnier BA; Fiessinger JN; Banga JD; Wenzel E; d'Azemar P; Sagnard L
    Thromb Haemost; 1998 May; 79(5):897-901. PubMed ID: 9609216
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).
    Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G;
    J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
    Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation.
    Partsch H
    Vasa; 2001 Jul; 30(3):195-204. PubMed ID: 11582950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis.
    Kakkar VV; Hoppenstead DA; Fareed J; Kadziola Z; Scully M; Nakov R; Breddin HK
    Blood; 2002 Mar; 99(6):1965-70. PubMed ID: 11877267
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy.
    Girard P; Decousus M; Laporte S; Buchmuller A; Hervé P; Lamer C; Parent F; Tardy B;
    Am J Respir Crit Care Med; 2001 Sep; 164(6):1033-7. PubMed ID: 11587992
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
    Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
    Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin.
    Harenberg J; Huisman MV; Tolle AR; Breddin HK; Kirchmaier CM
    Semin Thromb Hemost; 2001 Oct; 27(5):513-8. PubMed ID: 11668421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Anticoagulation in patients with venous thromboembolism].
    Rüfer A; Wuillemin WA
    Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.